免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Aspiron S ACP 系統

K 號:K220147 · 2022-02-16

決定日期2022-02-16
產品代碼KWQ
諮詢委員會或
決定相當於

器材摘要

Aspiron S ACP System is the device name listed in this FDA 510(k) record. The listed applicant is U&I Corporation. It received FDA 510(k) clearance on 2022-02-16 under 510(k) number K220147. The device is classified under product code KWQ. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Aspiron S ACP System?

Aspiron S ACP System is a medical device that received FDA 510(k) clearance on 2022-02-16. The listed applicant is U&I Corporation. The 510(k) number is K220147.

When did Aspiron S ACP System receive FDA 510(k) clearance?

Aspiron S ACP System received FDA 510(k) clearance on 2022-02-16, under 510(k) number K220147.

Who is the listed applicant for Aspiron S ACP System?

The FDA 510(k) record lists U&I Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Aspiron S ACP System?

The FDA product code for Aspiron S ACP System is KWQ.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 U&I Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 16 項裝置 →

相關器械(代碼:KWQ)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑